Results

• Please select a #tag from the overview (see above).
• To Our Shareholders
• Letter from Stefan Oschmann
• The Executive Board
• Our Shares
• In figures
• Management Report
• Fundamental Information about the Group
• The Group
• Our contributions to combating Covid-19
• Healthcare
• Life Science
• Performance Materials
• Strategy*
• Strategy Fundamentals
• Group Strategy
• Business Strategies
• Sustainability Strategy
• Strategic finance and dividend policy
• Internal Management System
• Key performance indicators
• Investments and value management
• Capital market-related parameters
• Other relevant/non-financial performance measures
• Sustainability*
• Innovations and technology
• Contribution of our technologies
• Sustainability culture and values
• Supply chain
• Social license
• Climate change and emissions
• Water and resource intensity
• Research and Development
• Healthcare*
• Life Science*
• Performance Materials*
• People*
• Leadership
• Talent
• Diversity and dialogue
• Differentiated solutions
• Report on Economic Position
• Macroeconomic Environment
• Review Forecast against Business Developments
• Course of Business and Economic Position
• Group
• Healthcare
• Life Science
• Performance Materials
• Corporate and Other
• Report on Risks and Opportunities
• Business-related risks and opportunities
• Financial risks and opportunities
• Legal risks
• Human resources risks
• Information technology risks
• Environmental, climate related and safety risks
• Risks due to the divestment, acquisition, and integration of companies and businesses
• Management assessment
• Report on Expected Developments
• Report in accordance with section 315 (4) of the German Commercial Code (HGB)
• Additional Information in accordance with the German Commercial Code (HGB)
• Corporate Governance
• Capital Structure and Corporate Bodies
• Statement on Corporate Governance
• Compensation Report
• Corporate governance practices
• Procedures of the Executive Board, Supervisory Board, Board of Partners, and its Committees
• Promote women in management positions
• Diversity policy
• Report of the Supervisory Board
• Objectives of the Supervisory Board
• Consolidated Financial Statements
• Income Statement
• Statement of Comprehensive Income
• Balance Sheet
• Cash Flow Statement
• Statement of Changes in Net Equity
• Notes
• General Disclosures
• (1) Company information
• (2) Reporting principles
• (3) Discretionary decisions and sources of estimation uncertainty
• (4) Subsequent events
• Group Structure
• (5) Changes in the scope of consolidation
• (6) Acquisitions and divestments
• (7) Collaboration and licensing agreements
• Operating Activities
• (8) Segment Reporting
• (9) Net sales
• (10) Cost of sales
• (11) Marketing and selling expenses
• (12) Research and development costs
• (13) Other operating income
• (14) Other operating expenses
• (15) Income tax
• (16) Net cash flows from operating activities
• (17) Earnings per share
• Operating Assets, Liabilities and Contingent Liabilities
• (18) Goodwill
• (19) Other intangible assets
• (20) Property, plant and equipment
• (21) Leasing
• (22) Other non-financial assets
• (23) Net cash flows from investing activities
• (24) Inventories
• (25) Trade and other receivables
• (26) Contract assets
• (27) Other provisions
• (28) Contingent liabilities
• (29) Other non-financial liabilities
• (30) Trade and other payables
• Employees
• (31) Number of employees
• (32) Personnel expenses
• (33) Provisions for employee benefits
• Capital Structure, Investments and Financing Activities
• (34) Equity
• (35) Cash and cash equivalents
• (36) Other financial assets
• (37) Financial debt/capital management
• (38) Other financial liabilities
• (39) Derivative financial instruments
• (40) Finance income and expenses/Net gains and losses from financial instruments
• (41) Net cash flows from financing activities
• (42) Management of financial risks
• (43) Information on fair value measurement
• (44) Other financial obligations
• Other Disclosures
• (45) Related party disclosures
• (46) Executive Board and Supervisory Board compensation
• (47) Auditor's fees
• (48) Corporate governance
• (49) Information on preparation and approval
• Scope of Consolidation
• (50) List of shareholdings
• Other Information
• Responsibility Statement
• Reproduction of the Independent Auditor's Report
• Business Development 2016 – 2020
• Financial Calendar